XML 18 R6.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2019
Mar. 31, 2018
Cash flows from operating activities:    
Consolidated net income $ 347 $ 395
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 366 347
Deferred income tax expense (benefit) 1 (15)
Interest accretion on landfill liabilities 23 23
Provision for bad debts 10 12
Equity-based compensation expense 27 23
Net gain on disposal of assets (2) (5)
(Gain) loss from divestitures, asset impairments and other, net 55 (3)
Equity in net losses of unconsolidated entities, net of dividends 9 7
Change in operating assets and liabilities, net of effects of acquisitions and divestitures:    
Receivables 212 183
Other current assets (9) (8)
Other assets (3) (1)
Accounts payable and accrued liabilities (117) (119)
Deferred revenues and other liabilities (29) (30)
Net cash provided by operating activities 890 809
Cash flows from investing activities:    
Acquisitions of businesses, net of cash acquired (394) (246)
Capital expenditures (471) (400)
Proceeds from divestitures of businesses and other assets (net of cash divested) 12 14
Other, net 53 (5)
Net cash used in investing activities (800) (637)
Cash flows from financing activities:    
New borrowings   61
Debt repayments (56) (80)
Net commercial paper borrowings 357 471
Common stock repurchase program (68) (250)
Cash dividends (223) (206)
Exercise of common stock options 25 23
Tax payments associated with equity-based compensation transactions (30) (28)
Other, net 37 (29)
Net cash provided by (used in) financing activities 42 (38)
Effect of exchange rate changes on cash, cash equivalents and restricted cash and cash equivalents   (1)
Increase in cash, cash equivalents and restricted cash and cash equivalents 132 133
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 183 293
Cash, cash equivalents and restricted cash and cash equivalents at end of period $ 315 $ 426